Author Index: S

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Sacks, R. M.
• PRESENTING COMPARATIVE COST INFORMATION TO CONSUMERS: EASIER SAID THAN DONE
Sadatsafavi, M.
• THE COST-EFFECTIVENESS MODEL OUTPUT TOOL
Sæther, E. M.
• DIAGNOSING HEART FAILURE WITH NT-PROBNP IN GENERAL PRACTICE: LOWER COSTS AND BETTER OUTCOME
Sahakyan, Y.
• MIXED METHOD PROGRAM EVALUATION OF THE TELEHOMECARE PROGRAM FOR PATIENTS WITH HEART FAILURE (HF) AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IN ONTARIO, CANADA: QUALITATIVE STUDY

• THE ROLE OF TELEHOMECARE ON BLOOD PRESSURE CONTROL IN PATIENTS WITH HEART FAILURE AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN ONTARIO, CANADA

• NEW MODEL OF HEALTHCARE DELIVERY: TELEHOMECARE PROGRAM FOR HEART FAILURE (HF) AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) PATIENTS IN ONTARIO, CANADA

• DIAGNOSTIC ACCURACY OF LEVEL IV PORTABLE SLEEP TESTS VERSUS POLYSOMNOGRAPHY FOR SLEEP-DISORDERED BREATHING: A SYSTEMATIC REVIEW AND META-ANALYSIS
Salkeld, G.
• THRESHOLD-BASED GUIDELINES THREATEN PREFERENCE-SENSITIVE DECISION MAKING IN PERSON-CENTRED CARE

• PRODUCING QUALITY-ADJUSTED OPINIONS FOR PREFERENCE-SENSITIVE MULTI-CRITERIAL DECISION SUPPORT
Samp, J.
• LONG-TERM EFFECTIVENESS AND COST EFFECTIVENESS OF DIFFERENT ANTIVIRAL TREATMENTS FOR CHRONIC GENOTYPE-1 HCV INFECTION IN GERMANY INCLUDING OMBITASVIR/PARITAPREVIR/RITONAVIR AND DASABUVIR

• DIRECT ANTIVIRAL DRUGS FOR THE TREATMENT OF CHRONIC HEPATITIS C PATIENTS WITH GENOTYPE 1 OR 4 IN FRANCE - COST-EFFECTIVENESS OF OMBITASVIR/PARITAPREVIR/RITONAVIR WITH OR WITHOUT DASABUVIR BY FIBROSIS SUBGROUP

• BUDGET IMPACT ANALYSIS INCLUDING OMBITASVIR/PARITAPREVIR/RITONAVIR AND DASABUVIR FOR THE TREATMENT OF CHRONIC HEPATITIS C IN FRANCE
Sandström, P.
• ECONOMIC EVALUATON OF NON-INVASIVE INVESTIGATION OF STATIC AND DYNAMIC LIVER FUNCTION TO ASSIST CLINICAL DECISION MAKING IN HEPATUCELLULAR CARCINOMA
Sarriugarte, G.
• PROBABILISTIC SENSITIVITY ANALYSIS OF COST-EFFECTIVENESS ANALYSIS OF THE BREAST CANCER SCREENING PROGRAMME IN THE BASQUE COUNTRY: A MULTI-COHORT DISCRETE-EVENT SIMULATION MODEL
Savic, A.
• COSTS OF FIRST-LINE TREATMENT FOR ELDERLY MULTIPLE MYELOMA PATIENTS WHO ARE NOT TRANSPLANT CANDIDATES IN THE SERBIAN HEALTH CARE SYSTEM
Schauppenlehner, M.
• MONITORING PRIMARY CARE - DEVELOPMENT OF DATA BASED INDICATORS FOR THE AUSTRIAN HEALTH SYSTEM
Scheid, D. C.
• DOES MEDICAL EDUCATION PROVIDE A SHARED UNDERSTANDING OF THE TREATMENT THRESHOLD PROBABILITY FOR SUSPECTED STREP THROAT?
Schulz, P.
• DEBIASING MEDICAL JUDGMENTS AND DECISION-MAKING – A SYSTEMATIC REVIEW
Schwartz, A.
• PHYSICIAN CHARACTERISTICS THAT PROMOTE OR IMPEDE CONTEXTUALIZED CARE PLANNING
Scott, H.
• EFFECTIVENESS OF DIETARY INTERVENTIONS IN CHRONIC KIDNEY DISEASE (CKD): A SYSTEMATIC REVIEW
Sculpher, M.
• WHEN AND WHERE IN THE TREATMENT PATHWAY IS IT APPROPRIATE TO USE NEW DIRECT ACTING ANTIVIRALS FOR CHRONIC HEPATITIS C?
Seaberg, P. H.
• DOES MEDICAL EDUCATION PROVIDE A SHARED UNDERSTANDING OF THE TREATMENT THRESHOLD PROBABILITY FOR SUSPECTED STREP THROAT?
Sevdalis, N.
• THE FEASIBILITY OF AN INNOVATIVE INTRA-OPERATIVE DECISION MAKING TRAINING COURSE
Shahid, N.
• MIXED METHOD PROGRAM EVALUATION OF THE TELEHOMECARE PROGRAM FOR PATIENTS WITH HEART FAILURE (HF) AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IN ONTARIO, CANADA: QUALITATIVE STUDY

• THE ROLE OF TELEHOMECARE ON BLOOD PRESSURE CONTROL IN PATIENTS WITH HEART FAILURE AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN ONTARIO, CANADA

• NEW MODEL OF HEALTHCARE DELIVERY: TELEHOMECARE PROGRAM FOR HEART FAILURE (HF) AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) PATIENTS IN ONTARIO, CANADA
Shaikh, T.
• SELECTIVE VERSUS ROUTINE SURGICAL RESECTION FOR RECTAL CANCER FOLLOWING NEOADJUVANT CHEMORADIATION AND CLINICAL COMPLETE RESPONSE
Sharma, G.
• PHYSICIAN CHARACTERISTICS THAT PROMOTE OR IMPEDE CONTEXTUALIZED CARE PLANNING
Sideris, E.
• PARTITIONED SURVIVAL ANALYSIS: A CRITICAL REVIEW OF THE APPROACH AND APPLICATION TO DECISION MODELLING IN HEALTH CARE
Siebert, U.
• IMPROVING CERVICAL CANCER PRIMARY SCREENING AND DIAGNOSTIC FOLLOW-UP IN AUSTRIA – A DECISION-ANALYTIC BENEFIT-HARM ANALYSIS

• HEALTH-ECONOMIC EVALUATION OF HPV-BASED CERVICAL CANCER PRIMARY SCREENING COMPARED TO CYTOLOGY OR P16/KI-67 DUAL-STAINING – A DECISION-ANALYSIS FOR THE AUSTRIAN HEALTH CARE CONTEXT

• LONG-TERM EFFECTIVENESS AND COST EFFECTIVENESS OF DIFFERENT ANTIVIRAL TREATMENTS FOR CHRONIC GENOTYPE-1 HCV INFECTION IN GERMANY INCLUDING OMBITASVIR/PARITAPREVIR/RITONAVIR AND DASABUVIR

• DIRECT ANTIVIRAL DRUGS FOR THE TREATMENT OF CHRONIC HEPATITIS C PATIENTS WITH GENOTYPE 1 OR 4 IN FRANCE - COST-EFFECTIVENESS OF OMBITASVIR/PARITAPREVIR/RITONAVIR WITH OR WITHOUT DASABUVIR BY FIBROSIS SUBGROUP

• THE BENEFIT-HARM BALANCE OF PROSTATE CANCER SCREENING IN MEN WITH AVERAGE AND ELEVATED FAMILIAL RISK – PREDICTIONS OF THE ONCOTYROL PROSTATE CANCER OUTCOME AND POLICY MODEL

• BUDGET IMPACT ANALYSIS INCLUDING OMBITASVIR/PARITAPREVIR/RITONAVIR AND DASABUVIR FOR THE TREATMENT OF CHRONIC HEPATITIS C IN FRANCE

• AN OVERVIEW OF DIFFERENT MAPPING TECHNIQUES TO DERIVE HEALTH STATE UTILITY VALUES IN MULTIPLE MYELOMA FOR DECISION-ANALYTIC MODELING

• COSTS OF FIRST-LINE TREATMENT FOR ELDERLY MULTIPLE MYELOMA PATIENTS WHO ARE NOT TRANSPLANT CANDIDATES IN THE SERBIAN HEALTH CARE SYSTEM

• META-ANALYSIS AND INDIRECT TREATMENT COMPARISON OF SAFETY PROFILES OF BORTEZOMIB- AND THALIDOMIDE-BASED REGIMENS FOR THE FIRST LINE TREATMENT OF ELDERLY TRANSPLANT-INELIGIBLE PATIENTS WITH MULTIPLE MYELOMA

• TREATMENT STRATEGIES FOR MULTIPLE MYELOMA IN ELDERLY PATIENTS: A NETWORK META-ANALYSIS

• SMDM CORE COURSE: INTRODUCTION TO MEDICAL DECISION ANALYSIS (DECISION-ANALYTIC MODELING)
Singh, S.
• ASSOCIATION OF DISEASE PROGRESSION, HEALTH-RELATED QUALITY OF LIFE, AND UTILITY IN PATIENTS WITH ADVANCED, NONFUNCTIONAL, WELL-DIFFERENTIATED GASTROINTESTINAL OR LUNG NEUROENDOCRINE TUMORS IN THE PHASE 3 RADIANT-4 TRIAL
Sirota, M.
• ‘1-IN-X' RATIOS LEAD TO MEDICAL PROBABILITY OVERESTIMATION
Skull, J.
• WHAT FACTORS INFLUENCE THE FERTILITY PRESERVATION TREATMENT DECISION-MAKING PROCESS IN WOMEN WITH CANCER? THE QUALITATIVE FINDINGS OF THE PREFER STUDY
Slade, P.
• WHAT FACTORS INFLUENCE THE FERTILITY PRESERVATION TREATMENT DECISION-MAKING PROCESS IN WOMEN WITH CANCER? THE QUALITATIVE FINDINGS OF THE PREFER STUDY
Slover, J.
• ASSOCIATION OF DEPRESSION WITH HOSPITAL LENGTH OF STAY AND 90-DAY READMISSION FOLLOWING TOTAL KNEE ARTHROPLASTY
Smets, E.
• ONCOLOGIST AND PATIENT QUESTIONS DURING CONSULTATIONS ABOUT ADJUVANT CANCER TREATMENT: A SHARED DECISION-MAKING PERSPECTIVE
Smets, E. M.
• DISCLOSING THE UNCERTAINTY OF PROGNOSTIC ESTIMATES IN BREAST CANCER: CURRENT PRACTICES AND PATIENTS' AWARENESS OF UNCERTAINTY
Smith, K. J.
• COST-EFFECTIVENESS OF AN INTERVENTION TO INCREASE VACCINATION RATES IN ADULTS <65 YEARS OLD
Smith, S.
• A SYSTEMATIC REVIEW OF ETHNICITY-SPECIFIC FACTORS INFLUENCING CHILDHOOD IMMUNISATION DECISIONS AMONG BLACK AND ASIAN MINORITY ETHNIC GROUPS IN THE UK
Soares, M.
• PARTITIONED SURVIVAL ANALYSIS: A CRITICAL REVIEW OF THE APPROACH AND APPLICATION TO DECISION MODELLING IN HEALTH CARE

• GENERATING AND USING ELICITED EVIDENCE FOR COST EFFECTIVENESS MODELS
Sørli, D.
• DIAGNOSING HEART FAILURE WITH NT-PROBNP IN GENERAL PRACTICE: LOWER COSTS AND BETTER OUTCOME
Soto-Gordoa, M.
• PROBABILISTIC SENSITIVITY ANALYSIS OF COST-EFFECTIVENESS ANALYSIS OF THE BREAST CANCER SCREENING PROGRAMME IN THE BASQUE COUNTRY: A MULTI-COHORT DISCRETE-EVENT SIMULATION MODEL
Southwell, B. G.
• CONVEYING UNCERTAINTY ABOUT PRICE SAVINGS AND RISK AND EFFICACY IN COMPARATIVE ADVERTISING FOR PRESCRIPTION DRUGS
Spooner, S.
• PREFERENCES, EXPECTATIONS AND CAREER CHOICES: A BEST WORST SCALING STUDY OF JUNIOR DOCTORS' CHOICE OF SPECIALISM IN ENGLAND
Sri Bhashyam, S.
• STRUCTURING BENEFIT-RISK MODELS IN PRESENCE OF NUMEROUS ADVERSE EVENTS: A CASE STUDY OF MULTIPLE SCLEROSIS
Sroczynski, G.
• IMPROVING CERVICAL CANCER PRIMARY SCREENING AND DIAGNOSTIC FOLLOW-UP IN AUSTRIA – A DECISION-ANALYTIC BENEFIT-HARM ANALYSIS

• HEALTH-ECONOMIC EVALUATION OF HPV-BASED CERVICAL CANCER PRIMARY SCREENING COMPARED TO CYTOLOGY OR P16/KI-67 DUAL-STAINING – A DECISION-ANALYSIS FOR THE AUSTRIAN HEALTH CARE CONTEXT

• LONG-TERM EFFECTIVENESS AND COST EFFECTIVENESS OF DIFFERENT ANTIVIRAL TREATMENTS FOR CHRONIC GENOTYPE-1 HCV INFECTION IN GERMANY INCLUDING OMBITASVIR/PARITAPREVIR/RITONAVIR AND DASABUVIR

• DIRECT ANTIVIRAL DRUGS FOR THE TREATMENT OF CHRONIC HEPATITIS C PATIENTS WITH GENOTYPE 1 OR 4 IN FRANCE - COST-EFFECTIVENESS OF OMBITASVIR/PARITAPREVIR/RITONAVIR WITH OR WITHOUT DASABUVIR BY FIBROSIS SUBGROUP

• THE BENEFIT-HARM BALANCE OF PROSTATE CANCER SCREENING IN MEN WITH AVERAGE AND ELEVATED FAMILIAL RISK – PREDICTIONS OF THE ONCOTYROL PROSTATE CANCER OUTCOME AND POLICY MODEL

• BUDGET IMPACT ANALYSIS INCLUDING OMBITASVIR/PARITAPREVIR/RITONAVIR AND DASABUVIR FOR THE TREATMENT OF CHRONIC HEPATITIS C IN FRANCE

• COSTS OF FIRST-LINE TREATMENT FOR ELDERLY MULTIPLE MYELOMA PATIENTS WHO ARE NOT TRANSPLANT CANDIDATES IN THE SERBIAN HEALTH CARE SYSTEM
Stanimirovic, A.
• MIXED METHOD PROGRAM EVALUATION OF THE TELEHOMECARE PROGRAM FOR PATIENTS WITH HEART FAILURE (HF) AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IN ONTARIO, CANADA: QUALITATIVE STUDY

• THE ROLE OF TELEHOMECARE ON BLOOD PRESSURE CONTROL IN PATIENTS WITH HEART FAILURE AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN ONTARIO, CANADA

• NEW MODEL OF HEALTHCARE DELIVERY: TELEHOMECARE PROGRAM FOR HEART FAILURE (HF) AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) PATIENTS IN ONTARIO, CANADA
Steegers, E.
• COST-EFFECTIVENESS OF PLANNED BIRTH IN A BIRTH CENTRE COMPARED WITH PLANNED BIRTH IN A HOSPITAL AND AT HOME IN WOMEN AT LOW-RISK OF COMPLICATIONS
Stein, K.
• EXPLICIT – DEVELOPING A PLATFORM FOR ELICITING EXPERT OPINION FOR MODEL-BASED ECONOMIC EVALUATIONS
Stevens, E. R.
• AN ALTERNATIVE APPROACH TO ESTIMATING MAXIMUM LIFE EXPECTANCY BASED ON SIMULATING AN OPTIMALLY HEALTHY POPULATION
Stevenson, M.
• RISK COMMUNICATION AND DECISIONS IN DEMENTIA: PROFESSIONAL PRACTICE PERSPECTIVES
Steyerberg, E. W.
• DISCRETE CHOICE EXPERIMENT AS A TOOL TO CHANGE MEDICAL PRACTICE EFFICIENTLY: AN APPLICATION TO BASAL CELL CARCINOMA FOLLOW-UP VISITS
Stiggelbout, A. M.
• DISCLOSING THE UNCERTAINTY OF PROGNOSTIC ESTIMATES IN BREAST CANCER: CURRENT PRACTICES AND PATIENTS' AWARENESS OF UNCERTAINTY

• ONCOLOGIST AND PATIENT QUESTIONS DURING CONSULTATIONS ABOUT ADJUVANT CANCER TREATMENT: A SHARED DECISION-MAKING PERSPECTIVE

• SMDM CORE COURSE: INTRODUCTION TO SHARED DECISION MAKING AND PATIENT DECISION AIDS

• TOP RATED ABSTRACTS
Stine, A.
• CONVEYING UNCERTAINTY ABOUT PRICE SAVINGS AND RISK AND EFFICACY IN COMPARATIVE ADVERTISING FOR PRESCRIPTION DRUGS
Stollenwerk, B.
• MODELLING ETELCALCETIDE EFFECTIVENESS ON HEALTH OUTCOMES: RELATING BIOCHEMICAL OUTCOMES TO MORTALITY, CARDIOVASCULAR EVENTS, FRACTURES AND PARATHYROIDECTOMY
Strang, J.
• CONTINGENCY MANAGEMENT IMPROVES COMPLETION OF HEPATITIS B VACCINATION IN THOSE ON TREATMENT FOR OPIATE DEPENDENCE: AN ECONOMIC EVALUATION
Strosberg, J.
• ASSOCIATION OF DISEASE PROGRESSION, HEALTH-RELATED QUALITY OF LIFE, AND UTILITY IN PATIENTS WITH ADVANCED, NONFUNCTIONAL, WELL-DIFFERENTIATED GASTROINTESTINAL OR LUNG NEUROENDOCRINE TUMORS IN THE PHASE 3 RADIANT-4 TRIAL
Strough, J.
• RESPONSES TO NARRATIVES BY RECIPIENTS VARYING IN NUMERACY
Suarez-Almazor, M.
• IMPACT OF DECISION-MAKING ROLE PREFERENCES IN THE EFFICACY OF A MULTIMEDIA PATIENT EDUCATION TOOL FOR PATIENTS WITH COMMON RHEUMATOLOGIC CONDITIONS
Sutton, M.
• PREFERENCES, EXPECTATIONS AND CAREER CHOICES: A BEST WORST SCALING STUDY OF JUNIOR DOCTORS' CHOICE OF SPECIALISM IN ENGLAND
Sy, S.
• COST-EFFECTIVE MANAGEMENT OF WOMEN WITH MINOR CERVICAL LESIONS: REVISITING THE APPLICATION OF HPV DNA TESTING
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z